Correlation of in vitro drug-sensitivity testing results with response to chemotherapy and survival in extensive-stage small cell lung cancer: A prospective clinical trial

Journal of the National Cancer Institute

Volumn 82, Issue 2, 1990, Pages 117-124

  Gazdar, Adi F ^a   Steinberg, Seth M ^a   Russell, Edward K ^a   Linnoila, R Ilona ^a   Oie, Herbert K ^a   Ghosh, Bimal C ^b   Cotelingam, James D ^c   Johnson, Bruce E ^a   Minna, John D ^a   Ihde, Daniel C ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b National Cancer Institute ^*  (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

^d UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; LOMUSTINE; METHOTREXATE; NIMUSTINE; VINCRISTINE;

ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CHEMOSENSITIVITY; CLINICAL TRIAL; CLONOGENIC ASSAY; DRUG SCREENING; HUMAN; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SMALL CELL; CLINICAL PROTOCOLS; CLINICAL TRIALS; DRUG SCREENING ASSAYS, ANTITUMOR; DYES; FEMALE; HUMAN; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; PROSPECTIVE STUDIES; TUMOR CELLS, CULTURED;

EID: 0025125820     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/82.2.117     Document Type: Article

References (20)

1. Morstyn G, Ihde DC, Lichter AS, et al: Small cell lung cancer 1973–1983: Early progress and recent obstacles, Int J Radiat Oncol Biol Phys 10:515–539, 1984
2. Johnson DH, Greco FA: Small cell carcinoma of the lung. CRC Crit Rev Oncol Hematol 4:303–336, 1986
3. Carney DN, Broder L, Edelstein M, et al: Experimental studies of the biology of human small cell lung cancer. Cancer Treat Rep 67:27–35, 1983
4. Carney DN, Gazdar AF, Cuttitta F, et al: In vitro studies of the biology of lung cancer. In Lung Cancer Causes and Prevention (Mizell M, Correa P, eds). Deerfield Beach, FL: Verlag Chemie lnt, 1984, pp 247–261
5. Gazdar AF, Carney DN, Nau MM, et al: Characterization of variant subclasses of cell lines derived from small cell lung cancer having distinctive biochemical, morphological and growth properties. Cancer Res 45:2924–2930, 1985
6. Simms E, Gazdar AF, Abrams PG, et al: Growth of human small cell (oat cell) carcinoma of the lung in serum-free growth factor supplemented medium. Cancer Res 40:4356–4363, 1980
7. Carney DN, Gazdar AF, Bepler C, et al: Establishment and identification of small cell lung cancer cell lines having classic and variant features. Cancer Res 45:2913–2923, 1985
8. Weisenthal LM, Morsden JA, Dill PL, et al: A novel dye exclusion method for testing in vitro chemosensitivity of human tumors. Cancer Res 43:749–757, 1983
9. Ihde DC, Deisseroth AB, Lichter AS, et al: Late intensive combined modality therapy followed by autologous bone marrow infusion in extensive stage small cell lung cancer. J Clin Oncol 4:1443–1454, 1986
10. Ihde DC, Johnson BE, Mulshine JL, et al: Randomized trial of high dose versus standard dose etoposide and cisplatin in extensive stage small cell lung cancer. Proc ASCO 6:181, 1987
11. Gazdar AF, Carney DN, Russell EK, et al: Establishment of continuous clonable cultures of small-cell carcinoma of the lung which have amine precursor uptake and decarboxylation cell properties. Cancer Res 40:3502–3507, 1980
12. Weisenthal LM, Dill PL, Kurnick NB, et al: Comparison of dye exclusion assays with a clonogenic assay in determination of drug- induced cytotoxicity. Cancer Res 43:258–264, 1983
13. Weisenthal LM, Nagourney RA, Kern DH, et al: Approach to clinical circumvention of drug resistance utilizing a non-clonogenic in vitro assay measuring the effects of drugs, radiation, and interleukin II on largely non-dividing cells. Adv Clin Oncol 1989. In press
14. Mantel N: Evaluation of survival data and two rank-order statistics arising in its consideration. Cancer Chemother Rep 50:163–170, 1966
15. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481, 1958
16. Fleiss JL: The Design and Analysis of Clinical Experiments. New York: Wiley, 1986
17. Carmichael J, Degraff WG, Gazdar AF, et al: Evaluation of a tetrazolium-based semiautomated colorimetric assay: Assessment of radiosensitivity. Cancer Res 47:943–946, 1987
18. Weisenthal LM: Clones, dyes, nuclides, mouse kidneys, and… virions: A new-clonogenic assay for tumor chemosensitivity. Eur J Cancer Clin Oncol 23:9–12, 1987
19. Volm M, Drings P, Halm EW, et al: Prediction of the clinical chemotherapeutic response of stage III lung adenocarcinoma patients by an in vitro short term test. Br J Cancer 57:198–200, 1988
20. Lai SL, Goldstein LJ, Gottesman MM, et al: MDR1 gene expression in lung cancer. J Natl Cancer Inst 81:1144–1150, 1989